Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure

Masahiro Mohri, Kensuke Egashira, Tatsuya Tagawa, Takeshi Kuga, Hirofumi Tagawa, Yasuhiko Harasawa, Hiroaki Shimokawa, Akira Takeshita

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

It is unknown whether basal release of endothelium-derived nitric oxide in the coronary artery is altered in heart failure in humans. The aim of the present study was to evaluate the effect of inhibition of nitric oxide synthesis on basal tone of the conduit and resistance coronary arteries in awake patients. Coronary blood flow velocity (Doppler guide wire) and coronary arterial diameter (quantitative coronary angiography) were measured in 14 patients with heart failure caused by nonischemic left ventricular dysfunction (7 idiopathic dilated cardiomyopathy and 7 valvular insufficiency) and 7 patients with normal ventricular function (controls). Intracoronary N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide synthesis, at graded doses decreased coronary blood flow in both groups. However, the magnitude of flow reduction was smaller in patients with heart failure than in control patients (P<.0001). The magnitude of coronary blood flow reduction in response to L-NMMA inversely correlated to indexes of left ventricular contractile function (P< 01) but was not affected by the cause of heart failure. Constriction of the large epicardial coronary artery with L-NMMA also tended to be attenuated in patients with heart failure. In summary, vasoconstricting response to L-NMMA was blunted in the coronary resistance artery in heart failure in vivo. These findings suggest that basal release of nitric oxide in the coronary circulation is decreased in patients with heart failure.

Original languageEnglish
Pages (from-to)50-56
Number of pages7
JournalHypertension
Volume30
Issue number1
DOIs
Publication statusPublished - Jul 1997

Fingerprint

Coronary Circulation
Nitric Oxide
Heart Failure
omega-N-Methylarginine
Coronary Vessels
Ventricular Function
Blood Flow Velocity
Dilated Cardiomyopathy
Left Ventricular Dysfunction
Coronary Angiography
Left Ventricular Function
Constriction
Arginine

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this

Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. / Mohri, Masahiro; Egashira, Kensuke; Tagawa, Tatsuya; Kuga, Takeshi; Tagawa, Hirofumi; Harasawa, Yasuhiko; Shimokawa, Hiroaki; Takeshita, Akira.

In: Hypertension, Vol. 30, No. 1, 07.1997, p. 50-56.

Research output: Contribution to journalArticle

Mohri, M, Egashira, K, Tagawa, T, Kuga, T, Tagawa, H, Harasawa, Y, Shimokawa, H & Takeshita, A 1997, 'Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure', Hypertension, vol. 30, no. 1, pp. 50-56. https://doi.org/10.1161/01.HYP.30.1.50
Mohri, Masahiro ; Egashira, Kensuke ; Tagawa, Tatsuya ; Kuga, Takeshi ; Tagawa, Hirofumi ; Harasawa, Yasuhiko ; Shimokawa, Hiroaki ; Takeshita, Akira. / Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. In: Hypertension. 1997 ; Vol. 30, No. 1. pp. 50-56.
@article{96c31256efb5432ba36b42f8c7c17394,
title = "Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure",
abstract = "It is unknown whether basal release of endothelium-derived nitric oxide in the coronary artery is altered in heart failure in humans. The aim of the present study was to evaluate the effect of inhibition of nitric oxide synthesis on basal tone of the conduit and resistance coronary arteries in awake patients. Coronary blood flow velocity (Doppler guide wire) and coronary arterial diameter (quantitative coronary angiography) were measured in 14 patients with heart failure caused by nonischemic left ventricular dysfunction (7 idiopathic dilated cardiomyopathy and 7 valvular insufficiency) and 7 patients with normal ventricular function (controls). Intracoronary N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide synthesis, at graded doses decreased coronary blood flow in both groups. However, the magnitude of flow reduction was smaller in patients with heart failure than in control patients (P<.0001). The magnitude of coronary blood flow reduction in response to L-NMMA inversely correlated to indexes of left ventricular contractile function (P< 01) but was not affected by the cause of heart failure. Constriction of the large epicardial coronary artery with L-NMMA also tended to be attenuated in patients with heart failure. In summary, vasoconstricting response to L-NMMA was blunted in the coronary resistance artery in heart failure in vivo. These findings suggest that basal release of nitric oxide in the coronary circulation is decreased in patients with heart failure.",
author = "Masahiro Mohri and Kensuke Egashira and Tatsuya Tagawa and Takeshi Kuga and Hirofumi Tagawa and Yasuhiko Harasawa and Hiroaki Shimokawa and Akira Takeshita",
year = "1997",
month = "7",
doi = "10.1161/01.HYP.30.1.50",
language = "English",
volume = "30",
pages = "50--56",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure

AU - Mohri, Masahiro

AU - Egashira, Kensuke

AU - Tagawa, Tatsuya

AU - Kuga, Takeshi

AU - Tagawa, Hirofumi

AU - Harasawa, Yasuhiko

AU - Shimokawa, Hiroaki

AU - Takeshita, Akira

PY - 1997/7

Y1 - 1997/7

N2 - It is unknown whether basal release of endothelium-derived nitric oxide in the coronary artery is altered in heart failure in humans. The aim of the present study was to evaluate the effect of inhibition of nitric oxide synthesis on basal tone of the conduit and resistance coronary arteries in awake patients. Coronary blood flow velocity (Doppler guide wire) and coronary arterial diameter (quantitative coronary angiography) were measured in 14 patients with heart failure caused by nonischemic left ventricular dysfunction (7 idiopathic dilated cardiomyopathy and 7 valvular insufficiency) and 7 patients with normal ventricular function (controls). Intracoronary N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide synthesis, at graded doses decreased coronary blood flow in both groups. However, the magnitude of flow reduction was smaller in patients with heart failure than in control patients (P<.0001). The magnitude of coronary blood flow reduction in response to L-NMMA inversely correlated to indexes of left ventricular contractile function (P< 01) but was not affected by the cause of heart failure. Constriction of the large epicardial coronary artery with L-NMMA also tended to be attenuated in patients with heart failure. In summary, vasoconstricting response to L-NMMA was blunted in the coronary resistance artery in heart failure in vivo. These findings suggest that basal release of nitric oxide in the coronary circulation is decreased in patients with heart failure.

AB - It is unknown whether basal release of endothelium-derived nitric oxide in the coronary artery is altered in heart failure in humans. The aim of the present study was to evaluate the effect of inhibition of nitric oxide synthesis on basal tone of the conduit and resistance coronary arteries in awake patients. Coronary blood flow velocity (Doppler guide wire) and coronary arterial diameter (quantitative coronary angiography) were measured in 14 patients with heart failure caused by nonischemic left ventricular dysfunction (7 idiopathic dilated cardiomyopathy and 7 valvular insufficiency) and 7 patients with normal ventricular function (controls). Intracoronary N(G)-monomethyl-L-arginine (L-NMMA), an inhibitor of nitric oxide synthesis, at graded doses decreased coronary blood flow in both groups. However, the magnitude of flow reduction was smaller in patients with heart failure than in control patients (P<.0001). The magnitude of coronary blood flow reduction in response to L-NMMA inversely correlated to indexes of left ventricular contractile function (P< 01) but was not affected by the cause of heart failure. Constriction of the large epicardial coronary artery with L-NMMA also tended to be attenuated in patients with heart failure. In summary, vasoconstricting response to L-NMMA was blunted in the coronary resistance artery in heart failure in vivo. These findings suggest that basal release of nitric oxide in the coronary circulation is decreased in patients with heart failure.

UR - http://www.scopus.com/inward/record.url?scp=0030802280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030802280&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.30.1.50

DO - 10.1161/01.HYP.30.1.50

M3 - Article

C2 - 9231820

AN - SCOPUS:0030802280

VL - 30

SP - 50

EP - 56

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -